Vol. 16 No. 1 (2010)

Published: 2010-01-01

Editorial

Time for a new business model?

Yali Friedman
- PDF

Commentary

Why data exclusivity is the new patent protection

Peter J Pitts
- PDF
Follow-on biologic drug competition â€“ No need for new marketing exclusivities

Michael S Wroblewski, Elizabeth A Jex
- Requires Subscription PDF (USD 25)

Article

Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb

Nigel Borshell, Adrian Dawkes
- PDF
Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms

Mark J Ahn, Michael Meeks, Sally Davenport, Rebecca Bednarek
- Requires Subscription PDF (USD 25)
Intellectual property landscape and patenting opportunity in biofuels

Ramasamy Mannan
- Requires Subscription PDF (USD 25)
Challenges and opportunities in the licensing of renewable technologies

Meredith Lloyd-Evans, Mike Gilbert, Ilian P Iliev
- Requires Subscription PDF (USD 25)
Ethiopia: Biotechnology for development

Desta Berhe Sbhatu
- Requires Subscription PDF (USD 25)
Innovation and commercialisation in the stem cell industries in Australia: State strategies and other opportunities to build a competitive position in the global stem cell economy

Olivia Harvey
- Requires Subscription PDF (USD 25)

Legal and Regulatory Updates

Using IP audits to optimize IP assets

James G Cullem
- Requires Subscription PDF (USD 25)

Book Review